Ameritas Investment Partners, Inc. Enanta Pharmaceuticals Inc Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,973 shares of ENTA stock, worth $18,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,973
Previous 1,973
-0.0%
Holding current value
$18,368
Previous $25,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$19.6 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$18.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$17.2 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$13.9 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$10.3 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $193M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...